Supreme Court To Reconsider “Rules Of the Road” In Generic Preemption

Design defect claims made against generic companies are focus of a case involving Mutual Pharmaceutical’s generic sulindac; ruling may eliminate lower court carve-outs to its Mensing decision.

More from United States

More from North America